Pimecrolimus received its initial approval from the U.S. Food and Drug Administration (FDA) on December 13, 2001.

Pimecrolimus is used for several dermatological purposes. Its primary use is in treating atopic dermatitis (eczema), particularly in cases where other treatments, such as topical corticosteroids, are ineffective or not recommended. It is also employed to manage seborrheic dermatitis, a condition affecting the scalp and face, and it can be used for contact dermatitis and intertrigo, both of which involve skin irritation and inflammation. 

Pimecrolimus is primarily administered topically, which is applied directly to the skin. It comes as a cream and is intended for external use only.  It's essential to follow the prescribed application instructions carefully and consult a healthcare provider for proper guidance on using this medication.

Some individuals may experience common side effects when using pimecrolimus, including mild burning or tingling sensations at the application site, itching, and temporary redness. Additionally, it's crucial to be aware of potential risks, such as worsening skin infections, if the cream is applied to infected skin. While rare, severe allergic reactions can occur, including rash, itching, swelling, severe dizziness, or difficulty breathing. 

Applying Pimecrolimus to infected skin could worsen the infection. This medication can make your skin more sensitive to sunlight. Temporary redness of the skin at the application site can occur. Rarely, severe allergic reactions may occur, including rash, itching, swelling, severe dizziness, or difficulty breathing.

Ensure that your skin is free of active infections before starting Pimecrolimus. Minimize sun exposure, especially during peak hours, and use protective clothing (e.g., long sleeves, hats) and sunscreen with high SPF when outdoors. Be aware of the signs of severe allergic reactions, such as rash, itching, swelling, dizziness, or difficulty breathing. If you experience any of these symptoms, seek immediate medical attention.

Avoid applying Pimecrolimus near sensitive areas such as the eyes, mouth, or mucous membranes, and ensure that the skin is intact and free of open wounds or infections before use. Protect yourself from sun exposure by using protective clothing and sunscreen with high SPF outdoors. Follow your healthcare provider's instructions regarding the frequency and duration of its use, and do not exceed the prescribed dosage. If using it on a child, adhere to pediatric-specific dosing guidelines. Additionally, discuss the duration of treatment, especially in children. Be vigilant for signs of severe allergic reactions and promptly report any unusual side effects to your healthcare provider. When possible, seek the guidance of a dermatologist or a healthcare provider with expertise in dermatology for personalized assessments and advice regarding its use.

1. Goodman & Gilman’s, The Pharmacological Basis of Therapeutics, Dermatological Pharmacology, 12th edition, 2011, 1822.
2. Mylan Products Ltd., Electronic medicines compendium (EMC), [Revised on 13th Apr 2022] [ Accessed on 6th September 2023], https://www.medicines.org.uk/emc/product/4966/pil#gref 
3. Mylan Products Ltd, US Food and Drug Administration, [Revised on October 2022] [ Accessed on 6th September 2023], https://www.accessdata.fda.gov/drugsatfda_docs/psg/PSG_021302.pdf 

The drug information on this page is not a substitute for medical advice; it is meant for educational purposes only. For further details, consult your doctor about your medical condition to know if you can receive this treatment.